CHMP5 and COVID-19: A recent 12-month longitudinal study showed that among convalescent COVID-19 plasma donors, the positive rate of IgG antibody against the SARS-CoV-2 receptor binding domain (RBD) in the spike protein exceeded 70% for 12 months post-diagnosis [32].